KennethJaredHessDO

PubMed

• Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.
  Fu, C.,Gombos, D. S.,Lee, J.,George, G. C.,Hess, K.,Whyte, A.,Hong, D. S.> ;Oncotarget. 2019 Mar 09
• Cancer-Related Internet Use and Online Social Networking Among Patients in an Early-Phase Clinical Trials Clinic at a Comprehensive Cancer Center.
  George, G. C.,Buford, A.,Hess, K.,Piha-Paul, S. A.,Zinner, R.,Subbiah, V.,Hinojosa, C.,Cleeland, C. S.,Meric-Bernstam, F.,Bernstam, E. V.,Hong, D. S.> ;JCO Clin Cancer Inform. 2019 Jan 18
• Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials.
  Sen, S.,Carmagnani Pestana, R.,Hess, K.,Viola, G.,Subbiah, V.> ;Ann. Oncol.. 2018 Oct 12
• HASH(0x2f65d48)
  Wang, Y.,Wang, Z.,Piha-Paul, S.,Janku, F.,Subbiah, V.,Shi, N.,Hess, K.,Broaddus, R.,Shan, B.,Naing, A.,Hong, D.,Tsimberidou, A. M.,Karp, D.,Lu, C.,Papadimitrakopoulou,...> ;Oncotarget. 2018 Oct 04
• Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic.
  Dembla, V.,Somaiah, N.,Barata, P.,Hess, K.,Fu, S.,Janku, F.,Karp, D. D.,Naing, A.,Piha-Paul, S. A.,Subbiah, V.,Tsimberidou, A. M.,Shaw, K.,Meric-Bernstam, F.,Hong, D. S.> ;Oncotarget. 2018 Sep 22
• 27 citations
  Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials
  Hossein Maymani, Kenneth R. Hess, Roman Groisberg, David S. Hong, Aung Naing, Sarina Anne Piha-Paul, Filip Janku, Siqing Fu, Apostolia Maria Tsimberidou, Shubham Pant,...> ;Lung Cancer. 2018 Jun 1
• Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
  Sen, S.,Kato, S.,Agarwal, R.,Piha-Paul, S.,Hess, K.,Karp, D.,Janku, F.,Fu, S.,Naing, A.,Pant, S.,Falchook, G.,Tang, C.,Wu, X.,Ye, Y.,Tsimberidou, A.,Subbiah, V.,Kurzro...> ;Br. J. Cancer. 2018 Apr 27
• The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
  Hui, D.,Hess, K.,Dibaj, S. S.,Arthur, J.,Dev, R.,Dalal, S.,Reddy, S.,Bruera, E.> ;Cancer. 1900 Jan 01
• Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
  Sen, S.,Hess, K.,Hong, D. S.,Naing, A.,Piha-Paul, S.,Janku, F.,Fu, S.,Subbiah, I. M.,Liu, H.,Khanji, R.,Huang, L.,Moorthy, S.,Karp, D. D.,Tsimberidou, A.,Meric-Bernsta...> ;Br. J. Cancer. 2018 Feb 21
• Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.
  Groisberg, R.,Hong, D. S.,Behrang, A.,Hess, K.,Janku, F.,Piha-Paul, S.,Naing, A.,Fu, S.,Benjamin, R.,Patel, S.,Somaiah, N.,Conley, A.,Meric-Bernstam, F.,Subbiah, V.> ;J Immunother Cancer. 2017 Dec 20
• Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
  Iyer, P.,Dadu, R.,Ferrarotto, R.,Busaidy, N.,Habra, M. A.,Zafereo, M.,Gross, N. D.,Hess, K.,Gule-Monroe, M.,Williams, M. D.,Cabanillas, M.> ;Thyroid. 2017 Nov 23
• Effect of Lorazepam with Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients with Advanced Cancer Receiving Palliative Care
  Daniel Epner, Kenneth Hess, William Breitbart, Donna S Zhukovsky, Marieberta Vidal, Eduardo Bruera> ;JAMA. 2017 Oct 05
• 89 citations
  Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
  Sarika N. Rao, Mark Zafereo, Ramona Dadu, Naifa L. Busaidy, Kenneth R. Hess, Gilbert J. Cote, Michelle D. Williams, William N. William, Vlad C. Sandulache, Neil D. Gro...> ;Thyroid. 2017 May 1
• Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of t...
  Huang, M. L.,Hess, K.,Candelaria, R. P.,Eghtedari, M.,Adrada, B. E.,Sneige, N.,Fornage, B. D.> ;Eur Radiol. 2016 Nov 16
• Impact of Oncologists' Attitudes Toward End-of-Life Care on Patients' Access to Palliative Care.
  Hui D, Cerana MA, Park M, Hess K, Bruera E> ;Oncologist. 2016-09-01
• 399 citations
  The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
  Yan Michael Li, Dima Suki, Kenneth R. Hess, Raymond Sawaya> ;Journal of Neurosurgery. 2016 Apr 1
• 31 citations
  Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospe...
  Chad Tang, Kenneth R. Hess, Andrew J. Bishop, Hubert Y. Pan, Eva N. Christensen, James N Yang, Nizar M. Tannir, Behrang Amini, Claudio E. Tatsui, Laurence D. Rhines, P...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Sep 1
• A Diagnostic Model for Impending Death in Cancer Patients: Preliminary Report - Hui - 2015 - Cancer
  Kenneth Hess, Eduardo Bruera, David Hui> ;Wiley. 2015 Jul 29
• 12 citations
  Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
  Apostolia Maria Tsimberidou, Rabih Said, Kirk S. Culotta, Ignacio I. Wistuba, Jaroslav Jelinek, Siqing Fu, Gerald S. Falchook, Aung Naing, Sarina Anne Piha-Paul, Ralph...> ;Clinical Epigenetics. 2015 Mar 17
• Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors.
  Yao, J. C.,Phan, A. T.,Hess, K.,Fogelman, D.,Jacobs, C.,Dagohoy, C.,Leary, C.,Xie, K.,Ng, C. S.> ;Pancreas. 2014 Nov 27
• Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.
  Fu, S.,Hou, M. M.,Naing, A.,Janku, F.,Hess, K.,Zinner, R.,Subbiah, V.,Hong, D.,Wheler, J.,Piha-Paul, S.,Tsimberidou, A.,Karp, D.,Araujo, D.,Kee, B.,Hwu, P.,Wolff, R.,K...> ;Ann. Oncol.. 2015 Feb 12
• Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.
  Naing, A.,Dalal, S.,Abdelrahim, M.,Wheler, J.,Hess, K.,Fu, S.,Hong, D. S.,Janku, F.,Falchook, G. S.,Ilustre, A.,Ouyang, F.,Kurzrock, R.> ;Support Care Cancer. 2015 Feb 15
• 66 citations
  Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic
  Denis Leonardo Fontes Jardim, Chad Tang, Debora de Melo Gagliato, Gerald S. Falchook, Kenneth R. Hess, Filip Janku, Siqing Fu, Jennifer J. Wheler, Ralph Zinner, Aung N...> ;Clinical Cancer Research. 2014 Dec 15
• 30 citations
  Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit.
  Debora de Melo Gagliato, Denis Leonardo Fontes Jardim, Gerald S. Falchook, Chad Tang, Ralph Zinner, Jennifer J. Wheler, Filip Janku, Vivek Subbiah, Sarina Anne Piha-Pa...> ;Clinical Breast Cancer. 2014 Dec 1
• 10 citations
  Synergy Between VEGF/VEGFR Inhibitors and Chemotherapy Agents in the Phase I Clinic
  Chad Tang, Kenneth R. Hess, Denis Leonardo Fontes Jardim, Debora de Melo Gagliato, Apostolia Maria Tsimberidou, Gerald S. Falchook, Siqing Fu, Filip Janku, Aung Naing,...> ;Clinical Cancer Research. 2014 Dec 1
• Join now to see all

Journal Articles

• Characteristics and Outcomes of Patients with Advanced Sarcoma Enrolled in Early Phase Immunotherapy Trials  
  David S Hong, Neeta Somaiah, Anthony Conley, Shreyaskumar Patel, Filip Janku, Aung Naing, Kenneth Hess, Robert Benjamin, BioMed Central